For instance, Bcl-2 protein is aberrantly overexpressed in 20% of DLBCL cases due to chromosomal translocation t(14;18) that juxtaposes Bcl-2 to the immunoglobulin heavy chain gene enhancers resulting in survival promotion [53]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.